Stress and Hair Loss in Women: The Telogen Effluvium Connection

Finding clumps of hair in the shower drain or on your pillow is alarming — and when it happens during or after a period of intense stress, the connection can feel unmistakable. Stress-related hair loss in women is most commonly caused by a condition called telogen effluvium, a temporary but distressing form of diffuse hair shedding that affects the entire scalp rather than specific areas.

Telogen effluvium is the second most common form of hair loss overall and the most common cause of sudden, widespread shedding in women. Understanding how stress triggers this condition — and what you can do to support recovery — can help ease the anxiety that often accompanies it.

Understanding the Hair Growth Cycle

To understand telogen effluvium, you first need to know how hair grows. Every hair follicle on your scalp cycles independently through three phases:

Anagen (growth phase): This active growth phase lasts 2–7 years. At any given time, approximately 85–90% of your hair is in the anagen phase.

Catagen (transition phase): A brief 2–3 week transition during which the follicle shrinks and detaches from its blood supply.

Telogen (resting phase): The hair rests for about 3 months before being shed to make way for a new anagen hair. Normally, 10–15% of your hair is in telogen at any time, resulting in the loss of 50–100 hairs per day — which is considered normal shedding.

How Stress Triggers Telogen Effluvium

When the body experiences significant physiological or psychological stress, it can prematurely shift a large percentage of hair follicles from the anagen (growth) phase into the telogen (resting) phase. Instead of the normal 10–15% of follicles in telogen, as many as 30–50% may enter the resting phase simultaneously.

Because the telogen phase lasts approximately 3 months, the shedding typically begins 2–4 months after the stressful event — which is why many women do not immediately connect the hair loss to its trigger. By the time the shedding starts, the stressful event may have resolved, making the cause less obvious.

The mechanism involves cortisol and other stress hormones acting on the hair follicle. Cortisol can push follicles into premature catagen, while inflammatory cytokines released during stress can disrupt the normal growth cycle. The hypothalamic-pituitary-adrenal (HPA) axis, which regulates the stress response, has direct connections to hair follicle biology.

Common Triggers

Telogen effluvium can be triggered by a wide range of stressors, including:

Emotional stress: Severe emotional upheaval — grief, divorce, job loss, financial crisis — can trigger shedding. However, everyday stress alone is rarely sufficient; the stressor typically needs to be significant or prolonged.

Physical illness or surgery: High fevers, infections (including COVID-19), major surgery, and hospitalization are well-known triggers. Post-COVID telogen effluvium has become increasingly recognized, with studies showing that up to 30% of COVID-19 patients experience hair shedding 2–3 months after infection.

Childbirth: Postpartum hair loss is one of the most common forms of telogen effluvium. During pregnancy, high estrogen levels keep more hair in the growth phase. After delivery, hormone levels drop rapidly, and a large wave of hair enters telogen simultaneously. Shedding typically peaks 3–4 months postpartum.

Nutritional deficiencies: Iron deficiency (with or without anemia), zinc deficiency, vitamin D deficiency, and very low protein intake can all trigger or worsen telogen effluvium. Crash dieting and rapid weight loss are common precipitants.

Thyroid dysfunction: Both hypothyroidism and hyperthyroidism can cause diffuse hair shedding. Thyroid function should always be checked in women experiencing unexplained hair loss.

Medication changes: Starting or stopping certain medications — including oral contraceptives, antidepressants, retinoids, and anticoagulants — can trigger telogen effluvium.

Diagnosis and Evaluation

Telogen effluvium is typically diagnosed based on clinical history and examination. Key features include:

Diffuse thinning across the entire scalp (not patchy loss, which suggests alopecia areata or other conditions). A positive "hair pull test," where gentle traction on a group of hairs yields more than 6 hairs in telogen. A clear temporal relationship between a stressor and the onset of shedding 2–4 months later.

Lab work should include a complete blood count, ferritin (iron stores), thyroid function tests, vitamin D, zinc, and possibly a hormone panel to rule out other causes. In some cases, a scalp biopsy may be needed to distinguish telogen effluvium from other forms of hair loss.

Recovery and Treatment

The good news: Acute telogen effluvium is self-limiting. Once the trigger is removed or resolved, the hair follicles re-enter the anagen phase and regrowth begins. Most women see significant improvement within 6–12 months, though full recovery of hair density may take up to 18 months.

Address underlying causes: If lab work reveals iron deficiency, thyroid dysfunction, or nutritional gaps, correcting these is essential. Iron supplementation (if ferritin is below 30–40 ng/mL), thyroid medication, or dietary improvements can accelerate recovery.

Nutritional support: Ensure adequate protein intake (at least 0.8–1.0 grams per kilogram of body weight), along with iron-rich foods, zinc, biotin, and vitamin D. While no supplement can regrow hair overnight, addressing deficiencies removes a barrier to normal growth.

Stress management: If chronic stress is an ongoing factor, implementing stress reduction strategies — regular exercise, adequate sleep, mindfulness or meditation, therapy, and social support — can help prevent recurrence.

Be gentle with your hair: During the shedding phase, minimize heat styling, tight hairstyles, and harsh chemical treatments that can further stress fragile hair.

When Telogen Effluvium Becomes Chronic

In some cases, telogen effluvium persists beyond 6 months, becoming "chronic telogen effluvium." This is more common in women aged 30–60 and may fluctuate over months or years. While it can be frustrating, chronic telogen effluvium does not typically lead to complete baldness — shedding and regrowth tend to occur simultaneously, maintaining overall (though reduced) density.

If hair loss persists or worsens, or if you notice a widening part or receding hairline, it is important to be evaluated for other conditions such as female pattern hair loss (androgenetic alopecia), which requires different treatment approaches. A thorough evaluation with a licensed provider can distinguish between these conditions and guide appropriate treatment.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.